Bringing virtual reality to the lab at Novartis

At Novartis, virtual reality is used to understand complex interactions between molecules. It’s a way to facilitate communication between chemist and biologist about drug design and protein’s interactions.   Viktor Hornak, an investigator in the Global Discovery Chemistry department at the Novartis Institutes for BioMedical Research (NIBR), is driving an effort to adapt VR tools for use in the drug design process. He and his colleagues recognize a potential for VR to help drug hunters more quickly…

"Bringing virtual reality to the lab at Novartis"